Consistent with these reports, this study also demonstrated that anti-MDA5 antibody and anti-Ro-52 antibody were both specific biomarkers for DM/CADM-associated RP-ILD (8, 32). This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.